The manufacturer of Mifegymiso is blaming supply chain issues for a pending shortage of the product — just months after another shortage of the drug forced some patients to get surgical abortions instead.
from CBC | Health News https://ift.tt/ZiKfvDt
Aucun commentaire:
Enregistrer un commentaire